Crinetics Pharmaceuticals, Inc. (CRNX)
84.79
+0.10
(+0.12%)
USD |
NASDAQ |
Aug 24, 16:00
84.79
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Price : 84.79 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 84.70 | 84.76 | 84.69 | 84.69 | 2.017M |
| Aug 20, 2026 | 84.71 | 84.74 | 84.67 | 84.69 | 9.004M |
| Aug 19, 2026 | 84.75 | 84.78 | 84.69 | 84.69 | 2.141M |
| Aug 18, 2026 | 84.71 | 84.80 | 84.67 | 84.72 | 3.972M |
| Aug 17, 2026 | 84.62 | 84.76 | 84.61 | 84.75 | 1.639M |
| Aug 14, 2026 | 84.38 | 84.70 | 84.36 | 84.70 | 2.279M |
| Aug 13, 2026 | 84.67 | 84.71 | 84.40 | 84.44 | 1.289M |
| Aug 12, 2026 | 84.40 | 84.54 | 84.40 | 84.46 | 2.584M |
| Aug 11, 2026 | 84.25 | 84.38 | 84.20 | 84.36 | 1.422M |
| Aug 10, 2026 | 84.03 | 84.34 | 83.96 | 84.15 | 2.330M |
| Aug 07, 2026 | 83.95 | 84.30 | 83.86 | 84.08 | 1.942M |
| Aug 06, 2026 | 84.01 | 84.08 | 83.92 | 83.92 | 2.096M |
| Aug 05, 2026 | 83.95 | 84.06 | 83.83 | 84.00 | 2.867M |
| Aug 04, 2026 | 83.78 | 84.02 | 83.75 | 83.86 | 2.726M |
| Aug 03, 2026 | 83.67 | 83.82 | 83.62 | 83.76 | 1.745M |
| Jul 31, 2026 | 83.75 | 83.80 | 83.47 | 83.52 | 1.864M |
| Jul 30, 2026 | 83.93 | 83.93 | 83.62 | 83.63 | 2.110M |
| Jul 29, 2026 | 83.89 | 83.96 | 83.82 | 83.88 | 1.622M |
| Jul 28, 2026 | 83.87 | 83.98 | 83.84 | 83.86 | 2.317M |
| Jul 27, 2026 | 83.80 | 84.00 | 83.67 | 83.85 | 5.217M |
| Jul 24, 2026 | 83.75 | 83.80 | 83.68 | 83.73 | 2.344M |
| Jul 23, 2026 | 83.78 | 83.79 | 83.64 | 83.65 | 4.269M |
| Jul 22, 2026 | 83.92 | 83.93 | 83.65 | 83.72 | 4.935M |
| Jul 21, 2026 | 83.93 | 84.00 | 83.87 | 83.90 | 2.735M |
| Jul 20, 2026 | 83.93 | 83.93 | 83.82 | 83.87 | 3.602M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 547.74 |
| Johnson & Johnson | 273.05 |
| Eli Lilly & Co. | 1247.64 |
| Pfizer Inc. | 27.98 |
| Bristol Myers Squibb Co. | 67.31 |
Price Related Metrics
| PS Ratio | 200.62 |
| PEG Ratio | -0.7410 |
| Price to Book Value | 7.527 |
| Earnings Yield | -5.95% |
| Market Cap | 8.971B |
| PEGY Ratio | -0.7410 |